These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15516857)

  • 1. B-type natriuretic Peptide and the right heart.
    Yap LB
    Heart Fail Rev; 2004 Apr; 9(2):99-105. PubMed ID: 15516857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension.
    Yap LB; Ashrafian H; Mukerjee D; Coghlan JG; Timms PM
    Clin Biochem; 2004 Oct; 37(10):847-56. PubMed ID: 15369714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides, respiratory disease, and the right heart.
    Yap LB; Mukerjee D; Timms PM; Ashrafian H; Coghlan JG
    Chest; 2004 Oct; 126(4):1330-6. PubMed ID: 15486400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
    Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension.
    Hargett CW; Tapson VF
    Semin Respir Crit Care Med; 2005 Aug; 26(4):385-93. PubMed ID: 16121315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension.
    Gan CT; McCann GP; Marcus JT; van Wolferen SA; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
    Eur Respir J; 2006 Dec; 28(6):1190-4. PubMed ID: 16971413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
    Veith C; Neghabian D; Luitel H; Wilhelm J; Egemnazarov B; Muntanjohl C; Fischer JH; Dahal BK; Schermuly RT; Ghofrani HA; Grimminger F; Fink L; Kwapiszewska G; Weissmann N; Sydykov A
    Basic Res Cardiol; 2020 Jan; 115(2):17. PubMed ID: 31980934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.
    Rain S; Handoko ML; Trip P; Gan CT; Westerhof N; Stienen GJ; Paulus WJ; Ottenheijm CA; Marcus JT; Dorfmüller P; Guignabert C; Humbert M; Macdonald P; Dos Remedios C; Postmus PE; Saripalli C; Hidalgo CG; Granzier HL; Vonk-Noordegraaf A; van der Velden J; de Man FS
    Circulation; 2013 Oct; 128(18):2016-25, 1-10. PubMed ID: 24056688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
    Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
    J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
    Vonk-Noordegraaf A; Haddad F; Chin KM; Forfia PR; Kawut SM; Lumens J; Naeije R; Newman J; Oudiz RJ; Provencher S; Torbicki A; Voelkel NF; Hassoun PM
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D22-33. PubMed ID: 24355638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension].
    Tian Z; Guo XX; Li MT; Wang Q; Liu YT; Zhao JL; Fang Q; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):102-6. PubMed ID: 21418827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional Echocardiography of Right Ventricular Function Correlates with Severity of Pediatric Pulmonary Hypertension.
    Jone PN; Patel SS; Cassidy C; Ivy DD
    Congenit Heart Dis; 2016 Dec; 11(6):562-569. PubMed ID: 26899626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.